Izycka, N.; Rucinski, M.; Andrzejewska, M.; Szubert, S.; Nowak-Markwitz, E.; Sterzynska, K.
The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients. Int. J. Mol. Sci. 2023, 24, 2400.
https://doi.org/10.3390/ijms24032400
AMA Style
Izycka N, Rucinski M, Andrzejewska M, Szubert S, Nowak-Markwitz E, Sterzynska K.
The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients. International Journal of Molecular Sciences. 2023; 24(3):2400.
https://doi.org/10.3390/ijms24032400
Chicago/Turabian Style
Izycka, Natalia, Marcin Rucinski, Malgorzata Andrzejewska, Sebastian Szubert, Ewa Nowak-Markwitz, and Karolina Sterzynska.
2023. "The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients" International Journal of Molecular Sciences 24, no. 3: 2400.
https://doi.org/10.3390/ijms24032400
APA Style
Izycka, N., Rucinski, M., Andrzejewska, M., Szubert, S., Nowak-Markwitz, E., & Sterzynska, K.
(2023). The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients. International Journal of Molecular Sciences, 24(3), 2400.
https://doi.org/10.3390/ijms24032400